Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CABLES1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
NKD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DOCK11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM172A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPT9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASPHD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPST1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL4R - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTURN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VMA21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYOM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPHS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF2AK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SAT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAPK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALG13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TACC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on